About the Collagen Cross-Linking Session
Collagen cross-linking (CXL) is a pivotal treatment in ophthalmology designed primarily for managing keratoconus, a condition where the cornea progressively thins and assumes a cone-like shape. This procedure involves applying riboflavin (vitamin B2) eye drops to the cornea, followed by exposure to ultraviolet A (UVA) light. This combination induces cross-links between collagen fibers within the cornea, bolstering its structural integrity and resilience.
The objective of CXL is to arrest the advancement of keratoconus by preventing further corneal bulging and preserving visual clarity. By fortifying the corneal tissue, CXL can potentially reduce reliance on rigid contact lenses and avert the necessity for more invasive treatments such as corneal transplants in severe cases. Successful outcomes hinge on meticulous patient selection and adherence to post-operative protocols to enhance effectiveness and mitigate risks associated with the procedure.
Topics Covered in Collagen Cross-Linking
Topic 01
Progressive Keratoconus
Topic 02
Riboflavin & UVA Exposure
Topic 03
Epi-On vs Epi-Off CXL
Topic 04
Accelerated CXL
Topic 05
Post-LASIK Ectasia
Topic 06
Scheimpflug Tomography
Featured Speakers — Collagen Cross-Linking 2027
Recent Research Presented at Collagen Cross-Linking Sessions
Safety and efficacy of small incision lenticule extraction combined with prophylactic corneal cross-linking (SMILE-Xtra) for myopia: a systematic review and meta-analysis
Introduction : Myopia is a common refractive error worldwide, and small incision lenticule extraction (SMILE) has become an established surgical option because of its favorable visual outcomes and…
Related Scientific Sessions at IOC 2027
Why Attend the Collagen Cross-Linking Conference 2027
Earn CPD Credit
Sessions are CPD-accredited by The CPD Group (UK) — one CPD credit for every hour of attendance.
Present Your Research
Oral and poster slots for original Collagen Cross-Linking work, reviewed by the scientific committee.
Network Globally
Meet ophthalmologists, vision scientists, and eye-care clinicians from around the world across three days.
Publish & Get Indexed
Accepted abstracts are compiled into the conference proceedings and indexed in Scopus and Web of Science.
Learn from Keynotes
Plenary lectures from leading voices shaping Collagen Cross-Linking research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join IOC 2027 for the Collagen Cross-Linking track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Collagen Cross-Linking Conference 2027 — FAQs
What is the Collagen Cross-Linking track at IOC 2027?
The Collagen Cross-Linking track is a dedicated stream within IOC 2027 covering the latest research, clinical innovation, and best practice in Collagen Cross-Linking. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Collagen Cross-Linking sessions?
Ophthalmologists, optometrists, vision scientists, educators, doctoral students, and trainees with an interest in Collagen Cross-Linking are all welcome — whether presenting or attending.
Can I present my research in the Collagen Cross-Linking track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Collagen Cross-Linking sessions?
Yes. IOC 2027 is a hybrid conference — attend the Collagen Cross-Linking track in person in Singapore or join live online, with on-demand access afterward.
Join the IOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Register as Delegate →
Attend without presenting.